Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis

OBJECTIVES: Treatment with trastuzumab and chemotherapy significantly improves the outcome in patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC). CT-P6 (trastuzumab-pkrb; Herzuma) is a trastuzumab biosimilar approved for the treatment of HER2-positiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joo-Hwan, Yeo, Ja Hyun, Kim, Young Saing, Park, Inkeun, Ahn, Hee Kyung, Cho, Eun Kyung, Shin, Dong Bok, Yang, Jun-Young, Kim, Hyung-Sik, Lee, Woon Kee, Sym, Sun Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles: Gastrointestinal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781232/
https://www.ncbi.nlm.nih.gov/pubmed/34991106
http://dx.doi.org/10.1097/COC.0000000000000887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781232/
https://www.ncbi.nlm.nih.gov/pubmed/34991106
http://dx.doi.org/10.1097/COC.0000000000000887

Ejemplares similares